Douglas P. Zipes MD
Distinguished Professor, Professor Emeritus of Medicine, Pharmacology and Toxicology, Emeritus Director of the Division of Cardiology and Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IndianaDr. Douglas P. Zipes is Distinguished Professor, Professor Emeritus of Medicine, Pharmacology and Toxicology, and Emeritus Director of the Division of Cardiology and Krannert Institute of Cardiology at Indiana University School of Medicine. He received his medical degree from Harvard Medical School and trained at Duke University Medical Center in medicine and cardiology. He joined Indiana University in 1970, became Distinguished Professor in 1994, and then Director of Cardiology (1995–2004).
Having published almost 1000 medical articles and 16 textbooks with multiple editions, Dr. Zipes is the recipient of numerous awards from the American Heart Association, the Heart Rhythm Society, the American College of Cardiology, and the European Society of Cardiology, among other professional societies and institutions.
He is past president of the American College of Cardiology and the Heart Rhythm Society, and past chair of the American Board of Internal Medicine. He is a fellow of the Heart Rhythm Society, American Heart Association, European Society of Cardiology. He is Master of the American College of Physicians and American College of Cardiology, and he is a member of the American Society for Clinical Investigation and the Association of American Physicians. In addition, Dr. Zipes retains honorary membership in the Cardiac Society of Australia and New Zealand, Argentine Society of Cardiology, Hungarian Society of Cardiology, and Israel Heart Society.
Recent Contributions to PracticeUpdate:
- Quality of Care Goes Up: Get With The Guidelines
- Implantable Defibrillator Therapy Before Death: High Risk for Painful Shocks at End of Life
- Outcomes in Catheter Ablation of Ventricular Tachycardia in Dilated Non-Ischemic Cardiomyopathy in Comparison to Ischemic Cardiomyopathy: Results From the Prospective HEart Centre of LeiPzig VT (HELP - VT) Study
- Atrial Fibrillation and the Risk of Myocardial Infarction
- Adult Congenital Heart Disease Over the Age of 60
- Temporal Trends in Quality of Care Among ICD Recipients: Insights From the NCDR®
- Atrial Fibrillation and the Risk of Myocardial Infarction
- Efficacy and Safety of Apixaban in Patients Following Cardioversion for AtrialFibrillation: Insights From the ARISTOTLE Trial
- AHA 2013 Recommended Abstracts: Electrophysiology and Myocyte Signaling and Ion Channels
- Diagnosis of Neurally Mediated Syncope at Initial Evaluation and With Tilt Table Testing Compared With That Revealed By Prolonged ECG Monitoring. An Analysis From the Third International Study on Syncope of Uncertain Etiology (ISSUE-3)